No abstract available
Keywords:
Aspergillose; Aspergillosis; Ibrutinib; Spondylodiscite; Spondylodiscitis.
MeSH terms
-
Adenine / administration & dosage
-
Adenine / adverse effects
-
Adenine / analogs & derivatives*
-
Aged
-
Antifungal Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Aspergillosis / drug therapy
-
Aspergillosis / microbiology*
-
Aspergillosis / surgery
-
Aspergillus / drug effects
-
Aspergillus / isolation & purification*
-
Combined Modality Therapy
-
Discitis / drug therapy
-
Discitis / microbiology*
-
Discitis / surgery
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects*
-
Laminectomy
-
Leukemia, Lymphocytic, Chronic, B-Cell / complications
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
-
Male
-
Piperidines / administration & dosage
-
Piperidines / adverse effects*
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / adverse effects*
-
Rituximab / administration & dosage
-
Rituximab / adverse effects
-
Voriconazole / therapeutic use
Substances
-
Antifungal Agents
-
Immunosuppressive Agents
-
Piperidines
-
Protein Kinase Inhibitors
-
ibrutinib
-
Rituximab
-
Adenine
-
Voriconazole